Under the terms of the merger agreement, iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share of iCAD common stock they hold at the closing of the merger. Based upon ...

Mark Koeniguer brings more than 30 years of experience leading and scaling MedTech, AI, and digital health companies to iCAD. Most recently, he served as CEO of ScreenPoint Medical, where he ...